# Triazolam Trial In Healthy Subjects To Compare Bioavailability Between Formulations Of Triazolam To Determine Their Bioequivalence In Terms Of Rate And Magnitude Of Absorption

> **NCT01017926** · PHASE1 · WITHDRAWN · sponsor: **Pfizer**

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Triazolam
- **DRUG:** Triazolam

## Key facts

- **NCT ID:** NCT01017926
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2010-08
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2016-04-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01017926

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01017926, "Triazolam Trial In Healthy Subjects To Compare Bioavailability Between Formulations Of Triazolam To Determine Their Bioequivalence In Terms Of Rate And Magnitude Of Absorption". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT01017926. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*